Neoadjuvant Therapy for Postmenopausal Women With ER and/or PgR Positive Breast Cancer. A Randomized Open Phase II Trial Evaluating the Efficacy of a 6 Months Preoperative Treatment With Letrozole (2.5 mg/Day) With or Without Zoledronic Acid (4 mg Every 4 Weeks)

Name: Neoadjuvant Therapy for Postmenopausal Women With ER and/or PgR Positive Breast Cancer. A Randomized Open Phase II Trial Evaluating the Efficacy of a 6 Months Preoperative Treatment With Letrozole (2.5 mg/Day) With or Without Zoledronic Acid (4 mg Every 4 Weeks)
Creator: Vivli
Published: 2025-10-01T20:10:35+08:00

DataCite Commons2025-10-01 更新2026-05-07 收录

乳腺癌内分泌治疗

唑来膦酸

数据链接：

https://search.vivli.org/doiLanding/studies/PR00011824/isLanding 数据链接链接失效反馈

官方服务：

资源简介：

This study will evaluate the safety/efficacy of zoledronic acid when given by intravenous infusion every 4 weeks in addition to letrozole as endocrine therapy in postmenopausal patients with hormone responsive breast cancer

提供机构：

Vivli

创建时间：

2025-10-01